1. Pink Sheet

US FDA Holds First Hybrid Meeting With Industry

 
• By Derrick Gingery

A Type A meeting was held in-person with a virtual contingent, the FDA clarified to the Pink Sheet. Several other meeting requests received were eligible, but did not seek an in-person session.

FDA headquarters
Sponsors are once again meeting with FDA staff in person at the agency's White Oak, MD headquarters. • Source: Shutterstock

The first in-person meeting between the sponsor and US Food and Drug Administration since the COVID-19 pandemic took hold occurred this week and more are upcoming.

The Center for Drug Evaluation and Research clarified on 29 March that three in-person meetings have been received and scheduled

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Review Pathways

More from Pathways & Standards